Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetes
April 24, 2025 01:00 ET | Source: Zealand Pharma Press release –…
Persephone Biosciences Announces First Subject Enrolled in ARTEMIS Clinical Trial of New Infant Synbiotic
SAN DIEGO, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Persephone Biosciences Inc., a…